Registration and Coffee
Chairperson's Opening Remarks
MACRO-OUTLOOK AND TRENDS
TECHNOLOGICAL BREAKTHROUGH: How Blockchains revolutionize End to End Supply Chains
• New perspectives
Olivier Brusle, Managing Director, Supply Chain Foundation & President of Actiom
GLOBAL VS LOCAL: How to globalize pharma products but reach the locals
• Why do we need to go Global, if I am locally sufficient and vice versa?
• What are the pros and cons of each?
• Can we have the best of both worlds? If yes, then how?
Ansu Archana, Senior Manager Sourcing & Strategic Supply Europe, Glenmark Pharma
Networking Break
PRODUCT LOSS: When problems in Product Transportation and Storage occurs. What are the Best practices to handle product loss
• Pharma Insurance coverage – are you really covered?
• Handling of lost/damaged cargo – Dos and Don’ts
• Loss prevention – practical aspects
• Reports and managerial tools
Yoram Eshel, Senior Director Head of Global Transportation, TEVA
Building a business case for a Label and Artwork Management System
● Calculating Return on Investment as a result of this change
● Aligning new systems to corporate strategies
● Exploring the other ROI (Risk of Ignoring) and possible effects on your business
Stephen Kaufman, Chief Product Officer, Blue Software
CASE STUDY
Ireland: Global hub of substance for the biopharma sector
• Key policy objectives for the sector
• Ireland: A Model of Substance campaign
Matt Moran, Director, BioPharmaChem Ireland
Networking Lunch
REGULATORY CONVERGENCE AND PROCEDURES
Disappearance of Global Regulatory Convergence
• General trends
• Risk and opportunity
Georges France, VP LOCs & Global Quality Lead, GSK
Outsourcing: When does it add value to a pharma supply chain?
• From subcontracting to partnership: stages on relationships
Diana Contreras, Senior Supply Chain Manager, Vertex
Networking Break
SECURITY AND MONITORING
Importance of monitoring for distribution of temperature sensitive products
• What Risk Techniques can help us to determine the right balance
• How temperature monitors with advanced techniques can help us be on the safe side
Viliam Kovac, Head of Global Supply Quality, Roche
PANEL DISCUSSION
Pharma Supply Chain in 2018: When experts from 4 world zones meet
• Understanding “how it works” in other countries
• Capturing new and innovative ideas
Gianpiero Lorusso, Director Supply Chain Operations, Merck Group
Kulwant Pawar, Professor of Operations Management and Director of the Centre for Concurrent Enterprise, Nottingham University Business School
(4-speakers Panel Discussion: Europe, USA, MENA, East Countries)
Chairperson’s Closing Remarks
Registration and Coffee
Chairperson’s Welcome Remarks
PHARMA SUPPLY CHAIN: FROM MANUFACTURER TO FINAL USER
New approach in COLD SUPPLY CHAIN
• Temperature sensitive equipment
• Is it possible in Emerging markets?
Fully Integrated End-to-End Supply Chain – is it worth the effort?
• Unexpected benefits and roadblocks
• Exploring the technology options
Peter Kalinski, Director Supply Chain, J&J Consumer EMEA
Networking Break
Cost optimization: How to optimize your global production network from a supply chain perspective
• Linking supply chain strategy and financial performance
• Barriers of success, including regulatory challenges
Bjørn Mogensen, VP DFP Business Support, Novo Nordisk
Wholesale distribution in an age of change
• From supply chain to value chain – powered by partnerships
• Challenges and opportunities in an age of change
Martin Fitzgerald, Deputy Director General, GIRP
CASE STUDY
New Automation processes in warehouse operations
• Installation of automation in a new warehouse of a fill&finish site
Gianpiero Lorusso, Director Supply Chain Operations, Merck Group
Networking Lunch
Reconfiguring Pharmaceutical Supply Chains
• How might Industry 4.0 technologies transform the supply of medicines?
• What are the patient benefits of digitalisation of pharmaceutical supply chains?
Jag Srai, Leader REMEDIES
Pre-Pharma Supply Chain: Raw Materials and Ingredients supply chain
• Differences and similarities with supply chain of final product
• Budget considerations
Murilo Coube, Supply Operations Specialist, MSD
Networking Break
POST- PHARMA SUPPLY CHAIN
The “Last Mile” Challenge
• Representation of the Company
• The “Last stop” in pharma supply chain before the Final User: How can Marketing help?
Marion Matthewman, Head Global Logistics, Syngenta
PANEL DISCUSSION
Pharma Companies Vs. Cargo Companies
• When the relationship works and when it doesn’t (real case examples)
• Challenges and Opportunities for future collaborations as seen from the two points of view
(4-speakers Panel Discussion: 2 from Big Pharmaceutical Companies and 2 from Big Cargo Companies)
Panelists:
Diana Contreras, Senior Supply Chain Manager, Vertex
Stephen Mitchell, Compliance and Quality Manager Logistics, GSK
Francisco Rizzuto, International Cargo Management Professional, IATA
